It is no secret that psychedelic companies are making a move to overtake Selective Serotonin Reuptake Inhibitors (SSRIs) as the primary treatment for depression. So, when the Chemical Imbalance Theory came into question last year, many people in the industry were excited. Unfortunately, the scientists attempting to throw out the baby with the bathwater didn’t…